RESPONSE BY STAGE IN CD30-POSITIVE (CD30+) CUTANEOUS T CELL LYMPHOMA (CTCL) PATIENTS RECEIVING BRENTUXIMAB VEDOTIN (BV) VS PHYSICIAN'S CHOICE (PC) IN THE PHASE 3 ALCANZA STUDY
2017 ◽
Vol 35
◽
pp. 245-247
S. Horwitz
◽
S. Whittaker
◽
M. Duvic
◽
R. Dummer
◽
Y.H. Kim
◽
...
2017 ◽
Vol 390
(10094)
◽
pp. 555-566
◽
H Miles Prince
◽
Youn H Kim
◽
Steven M Horwitz
◽
Reinhard Dummer
◽
Julia Scarisbrick
◽
...
2019 ◽
Vol 37
◽
pp. 286-288
◽
S.M. Horwitz
◽
J. Scarisbrick
◽
H.M. Prince
◽
S. Whittaker
◽
M. Duvic
◽
...
2017 ◽
Vol 137
(5)
◽
pp. S45
◽
Y.H. Kim
◽
S. Whittaker
◽
S.M. Horwitz
◽
M. Duvic
◽
R. Dummer
◽
...
Swaminathan Iyer
◽
Lorenz Trümper
◽
Owen A. O’Connor
◽
Barbara Pro
◽
Tim Illidge
◽
...
2018 ◽
Vol 178
(1)
◽
pp. 302-303
◽
D.J. Lewis
◽
Y.H. Kim
◽
M. Duvic
2019 ◽
Vol 119
◽
pp. S34-S35
E. Papadavid
◽
V. Pappa
◽
E. Kapniari
◽
V. Nikolaou
◽
T. Hliakis
◽
...
2017 ◽
Vol 13
(27)
◽
pp. 2405-2411
◽
2019 ◽
Vol 95
(3)
◽
pp. 129-135
József Szakonyi
◽
◽
Veronika Tóth
◽
Béla Tóth
◽
Ágota Szepesi
◽
...
2019 ◽
Vol 393
(10168)
◽
pp. 229-240
◽
Steven Horwitz
◽
Owen A O'Connor
◽
Barbara Pro
◽
Tim Illidge
◽
Michelle Fanale
◽
...
Close
Export Citation Format
Close
Share Document
Close